EUVIMEDSkopri EUVIMED
CrossrefKarta ta’ informazzjoni

Development of AA Amyloidosis in a Patient with Psoriasis: A Case Report

Mehmet SEZEN, Müge ŞAHİN, Abdülmecit YILDIZ, Ayşegül ORUÇ, Saide GÜLLÜLÜ, Mahmut YAVUZ, Mustafa GÜLLÜLÜ, Kamil DİLEK, Alparslan ERSOY

Turkish Journal of Internal Medicine · 2022

DOI: 10.46310/tjim.1072829 ↗
AstrattDettalji biblijografiċi

Astratt

Psoriasis is a chronic, recurrent, inflammatory and common skin disease of unknown aetiology. Amyloidosis is defined as a heterogeneous group of diseases in which generally soluble plasma proteins accumulate in the extracellular space as insoluble abnormal fibrils. Type AA amyloidosis is a late and severe complication of chronic inflammatory disorders and some chronic infections. Although psoriasis is a common inflammatory skin disease, the development of amyloidosis is rare. Herein, we presented a case of psoriasis who developed AA-type amyloidosis.

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.

Ara t-tariffi →